Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects

Completed · Phase 2/Phase 3

Conditions studied: Alzheimer's Disease

In brief

A Phase 2/3 cross-sectional and longitudinal observational study evaluating imaging characteristics of flortaucipir in control subjects and patients with clinically defined MCI and AD dementia (AD).

Key facts

Study ID
NCT02016560
Run by
Avid Radiopharmaceuticals
People needed
383
Starts
2013-12-01
Expected to finish
2017-07-28
Last updated by the study team
2020-09-22

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.